The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Open accessAbstract
To study HIV-1 escape from a coreceptor antagonist, the R5 primary isolate CC1/85 was passaged in peripheral blood mononuclear cells with increasing concentrations of the CCR5-specific small molecule inhibitor, AD101. By 19 passages, an escape mutant emerged with a >20,000-fold resistance to AD101. This virus was cross-resistant to a related inhibitor, SCH-C, and partially resistant to RANTES but still sensitive to CCR5-specific mAbs. The resistant phenotype was stable; the mutant virus retained AD101 resistance during nine additional passages of culture in the absence of inhibitor. Replication of the escape mutant in peripheral blood mononuclear cells completely depended on CCR5 expression and did not occur in cells from CCR5-Δ32 homozygous individuals. The escape mutant was unable to use CXCR4 or any other tested coreceptor to enter transfected cells. Acquisition of CXCR4 use is not the dominant in vitro escape pathway for a small molecule CCR5 entry inhibitor. Instead, HIV-1 acquires the ability to use CCR5 despite the inhibitor, first by requiring lower levels of CCR5 for entry and then probably by using the drug-bound form of the receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
Self-citationFouchier, R. A., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F., & Schuitemaker, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3183-3187.1992 · Cited by 770
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Self-citationMack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1373 · Cited by 357
Self-citationMörner, A., Björndal, Å., Albert, J., KewalRamani, V. N., Littman, D. R., Inoue, R., Thorstensson, R., Fenyö, E. M., & Björling, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2343-2349.1999 · Cited by 328
HIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Strizki, J. M., Xu, S., Wagner, N. E., Wojcik, L., Liu, J., Hou, Y., Endres, M., Palani, A., Shapiro, S., Clader, J. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221375398 · Cited by 299
Self-citationBlaak, H., van't Wout, A. B., Brouwer, M., Hooibrink, B., Hovenkamp, E., & Schuitemaker, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1269 · Cited by 262
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Self-citationHIV-1 Actively Replicates in Naive CD4+ T Cells Residing within Human Lymphoid Tissues
Eckstein, D. A., Penn, M. L., Korin, Y. D., Scripture-Adams, D. D., Zack, J. A., Kreisberg, J. F., Roederer, M., Sherman, M. P., Chin, P. S., & Goldsmith, M. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00217-5 · Cited by 232
Olson, W. C., Rabut, G. E. E., Nagashima, K. A., Tran, D. N. H., Anselma, D. J., Monard, S. P., Segal, J. P., Thompson, D. A. D., Kajumo, F., Guo, Y., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4145-4155.1999 · Cited by 224
Self-citationKuhmann, S. E., Platt, E. J., Kozak, S. L., & Kabat, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7005-7015.2000 · Cited by 223
Self-citationHIV Treatment Failure: Testing for HIV Resistance in Clinical Practice
Perrin, L., & Telenti, A. (1998) · Science · doi:10.1126/science.280.5371.1871 · Cited by 193
Mosier, D. E., Picchio, G. R., Gulizia, R. J., Sabbe, R., Poignard, P., Picard, L., Offord, R. E., Thompson, D. A., & Wilken, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3544-3550.1999 · Cited by 182
Cornelissen, M., Mulder-Kampinga, G., Veenstra, J., Zorgdrager, F., Kuiken, C., Hartman, S., Dekker, J., van der Hoek, L., Sol, C., & Coutinho, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1810-1818.1995 · Cited by 176
New targets for inhibitors of HIV-1 replication
Moore, J. P., & Stevenson, M. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036060 · Cited by 167
Self-citationBoyd, M. T., Simpson, G. R., Cann, A. J., Johnson, M. A., & Weiss, R. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3649-3652.1993 · Cited by 154
Cheng‐Mayer, C., Shioda, T., & Levy, J. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6931-6941.1991 · Cited by 139
HIV-1 entry inhibitors: Evading the issue
Michael, N. L., & Moore, J. P. (1999) · Nature Medicine · doi:10.1038/10462 · Cited by 135
Self-citationThe molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
de Vreese, K., Kofler-Mongold, V., Leutgeb, C., Weber, V., Vermeire, K., Schacht, S., Anné, J., Clercq, E. D., DATEMA, R., & Werner, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.689-696.1996 · Cited by 130
Trkola, A., Paxton, W. A., Monard, S. P., Hoxie, J. A., Siani, M. A., Thompson, D. A., Wu, L., Mackay, C. R., Horuk, R., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.396-404.1998 · Cited by 122
Self-citationSchols, D., Esté, J. A., Cabrera, C., & Clercq, E. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4032-4037.1998 · Cited by 109
Maas, J., Gange, S. J., Schuitemaker, H., Coutinho, R. A., van Leeuwen, R., & Margolick, J. B. (2000) · AIDS · doi:10.1097/00002030-200006160-00012 · Cited by 56
Dejucq‐Rainsford, N., Simmons, G., & Clapham, P. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7842-7847.1999 · Cited by 48
Chemokine receptors and the clinical course of HIV-1 infection
Husman, A. D. R., & Schuitemaker, H. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01249-9 · Cited by 43
Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997?
Dodson, P. M., & Kritzinger, E. E. (1997) · Eye · doi:10.1038/eye.1997.2 · Cited by 23
Cited by
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999
“In practice, such an approach could theoretically complement the use of small-molecule CCR5 inhibitors, which may lead to the emergence of escape variants that retain tropism for CCR”
BackgroundHIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., & Melikyan, G. B. (2009) · Cell · doi:10.1016/j.cell.2009.02.046 · Cited by 681
Metadata
- Authors
- Trkola, A., Kuhmann, S. E., Strizki, J. M., Maxwell, E., Ketas, T., Morgan, T., Pugach, P., Xu, S., Wojcik, L., Tagat, J., Palani, A., Shapiro, S., Clader, J. W., McCombie, S., Reyes, G. R., Baroudy, B. M., & Moore, J. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-01-08
- Volume
- 99
- Issue
- 1
- Pages
- 395-400
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1966515400
- Cited by
- 303
- References
- 33
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.